These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 17404502)

  • 1. Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy.
    Ulasov IV; Rivera AA; Sonabend AM; Rivera LB; Wang M; Zhu ZB; Lesniak MS
    Cancer Biol Ther; 2007 May; 6(5):679-85. PubMed ID: 17404502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma.
    Van Houdt WJ; Haviv YS; Lu B; Wang M; Rivera AA; Ulasov IV; Lamfers ML; Rein D; Lesniak MS; Siegal GP; Dirven CM; Curiel DT; Zhu ZB
    J Neurosurg; 2006 Apr; 104(4):583-92. PubMed ID: 16619663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.
    Ulasov IV; Zhu ZB; Tyler MA; Han Y; Rivera AA; Khramtsov A; Curiel DT; Lesniak MS
    Hum Gene Ther; 2007 Jul; 18(7):589-602. PubMed ID: 17630837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.
    Tyler MA; Ulasov IV; Sonabend AM; Nandi S; Han Y; Marler S; Roth J; Lesniak MS
    Gene Ther; 2009 Feb; 16(2):262-78. PubMed ID: 19078993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy.
    Ulasov IV; Tyler MA; Zhu ZB; Han Y; He TC; Lesniak MS
    Int J Oncol; 2009 Mar; 34(3):729-42. PubMed ID: 19212678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of tumor-specific promoter activities in melanoma.
    Lu B; Makhija SK; Nettelbeck DM; Rivera AA; Wang M; Komarova S; Zhou F; Yamamoto M; Haisma HJ; Alvarez RD; Curiel DT; Zhu ZB
    Gene Ther; 2005 Feb; 12(4):330-8. PubMed ID: 15696177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo.
    Zhu ZB; Makhija SK; Lu B; Wang M; Rivera AA; Kim-Park S; Ulasov IV; Zhou F; Alvarez RD; Siegal GP; Curiel DT
    Int J Oncol; 2005 Jul; 27(1):237-46. PubMed ID: 15942665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells.
    Nandi S; Ulasov IV; Tyler MA; Sugihara AQ; Molinero L; Han Y; Zhu ZB; Lesniak MS
    Cancer Res; 2008 Jul; 68(14):5778-84. PubMed ID: 18632631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chimeric adenovirus with an Ad 3 fiber knob modification augments glioma virotherapy.
    Nandi S; Ulasov IV; Rolle CE; Han Y; Lesniak MS
    J Gene Med; 2009 Nov; 11(11):1005-11. PubMed ID: 19688792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional targeting of tumors with a novel tumor-specific survivin promoter.
    Zhu ZB; Makhija SK; Lu B; Wang M; Kaliberova L; Liu B; Rivera AA; Nettelbeck DM; Mahasreshti PJ; Leath CA; Barker S; Yamaoto M; Li F; Alvarez RD; Curiel DT
    Cancer Gene Ther; 2004 Apr; 11(4):256-62. PubMed ID: 15017380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer.
    Toyoda E; Doi R; Kami K; Mori T; Ito D; Koizumi M; Kida A; Nagai K; Ito T; Masui T; Wada M; Tagawa M; Uemoto S
    J Exp Clin Cancer Res; 2008 Aug; 27(1):30. PubMed ID: 18717994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting mesothelioma using an infectivity enhanced survivin-conditionally replicative adenoviruses.
    Zhu ZB; Makhija SK; Lu B; Wang M; Wang S; Takayama K; Siegal GP; Reynolds PN; Curiel DT
    J Thorac Oncol; 2006 Sep; 1(7):701-11. PubMed ID: 17409940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma.
    Sonabend AM; Ulasov IV; Tyler MA; Rivera AA; Mathis JM; Lesniak MS
    Stem Cells; 2008 Mar; 26(3):831-41. PubMed ID: 18192232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control.
    Stoff-Khalili MA; Rivera AA; Nedeljkovic-Kurepa A; DeBenedetti A; Li XL; Odaka Y; Podduturi J; Sibley DA; Siegal GP; Stoff A; Young S; Zhu ZB; Curiel DT; Mathis JM
    Breast Cancer Res Treat; 2008 Mar; 108(1):43-55. PubMed ID: 17508279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining high selectivity of replication via CXCR4 promoter with fiber chimerism for effective adenoviral oncolysis in breast cancer.
    Stoff-Khalili MA; Rivera AA; Stoff A; Michael Mathis J; Rocconi RP; Matthews QL; Numnum MT; Herrmann I; Dall P; Eckhoff DE; Douglas JT; Siegal GP; Zhu ZB; Curiel DT
    Int J Cancer; 2007 Feb; 120(4):935-41. PubMed ID: 17131341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midkine promoter-based conditionally replicative adenovirus for malignant glioma therapy.
    Kohno S; Nakagawa K; Hamada K; Harada H; Yamasaki K; Hashimoto K; Tagawa M; Nagato S; Furukawa K; Ohnishi T
    Oncol Rep; 2004 Jul; 12(1):73-8. PubMed ID: 15201962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection and comparison of transcriptional activities of tumor-specific survivin and alpha-fetoprotein promoters in human hepatocellular carcinoma cells].
    Kuang G; Huang AL; Tang N
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):440-2. PubMed ID: 15975279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.